CANC Holdings — Tema Oncology ETF
Data updated: 2026-07-29
CANC holds 57 securities. The top 10 make up 42.9% of net assets, led by Revolution Medicines (7.73%) and Eli Lilly & (4.82%). Health Care (98.9%) and Funds & ETFs (1.1%) are the largest sectors, and 80.9% of the portfolio is in United States. No debt holdings are reported.
Holdings cover 100.08% of net asset value (99.91% of total assets; remainder is cash and receivables). As of May 31, 2026 · N-PORT.
CANC Portfolio Holdings
57 holdings of Tema Oncology ETF by percentage of net assets, from the fund's SEC N-PORT filing as of May 31, 2026.
| Holding | Ticker | Sector | % of net assets | Value (USD) |
|---|---|---|---|---|
| Revolution Medicines Inc | RVMD | Health Care | 7.73% | $13.61M |
| Eli Lilly & Co | LLY | Health Care | 4.82% | $8.49M |
| Roche Holding AG | RHHBY | Health Care | 4.21% | $7.42M |
| Cogent Biosciences Inc | COGT | Health Care | 4.10% | $7.22M |
| Novartis AG | NOVN | Health Care | 4.03% | $7.10M |
| Immunome Inc | IMNM | Health Care | 3.91% | $6.89M |
| Celcuity Inc | CELC | Health Care | 3.58% | $6.31M |
| Merck & Co Inc | MRK | Health Care | 3.57% | $6.29M |
| AstraZeneca PLC | AZN | Health Care | 3.54% | $6.23M |
| Nuvalent Inc | NUVL | Health Care | 3.37% | $5.93M |
| Bristol-Myers Squibb Co | BMY | Health Care | 3.30% | $5.81M |
| Legend Biotech Corp | LEGN | Health Care | 2.99% | $5.27M |
| AbbVie Inc | ABBV | Health Care | 2.81% | $4.94M |
| Exelixis Inc | EXEL | Health Care | 2.78% | $4.89M |
| Bridgebio Pharma Inc | BBIO | Health Care | 2.75% | $4.85M |
| Johnson & Johnson | JNJ | Health Care | 2.55% | $4.48M |
| CG oncology Inc | CGON | Health Care | 2.43% | $4.28M |
| Genmab A/S | GMAB | Health Care | 2.37% | $4.18M |
| Ideaya Biosciences Inc | IDYA | Health Care | 2.27% | $4.00M |
| Amgen Inc | AMGN | Health Care | 2.11% | $3.71M |
| Zai Lab Ltd | ZLAB | Health Care | 1.98% | $3.48M |
| BeOne Medicines Ltd | ONC | Health Care | 1.88% | $3.31M |
| Zymeworks Inc | ZYME | Health Care | 1.51% | $2.65M |
| Enliven Therapeutics Inc | ELVN | Health Care | 1.31% | $2.30M |
| Relay Therapeutics Inc | RLAY | Health Care | 1.28% | $2.26M |
| Halozyme Therapeutics Inc | HALO | Health Care | 1.23% | $2.17M |
| Summit Therapeutics Inc | SMMT | Health Care | 1.21% | $2.12M |
| Arcus Biosciences Inc | RCUS | Health Care | 1.20% | $2.11M |
| Gilead Sciences Inc | GILD | Health Care | 1.12% | $1.98M |
| Immatics NV | IMTX | Health Care | 1.12% | $1.97M |
| First American Treasury Obligations Fund | FXFXX | Funds & ETFs | 1.09% | $1.92M |
| Erasca Inc | ERAS | Health Care | 1.08% | $1.90M |
| Nuvation Bio Inc | NUVB | Health Care | 1.07% | $1.89M |
| AnaptysBio Inc | ANAB | Health Care | 0.99% | $1.74M |
| UroGen Pharma Ltd | URGN | Health Care | 0.93% | $1.65M |
| Guardant Health Inc | GH | Health Care | 0.81% | $1.42M |
| Syndax Pharmaceuticals Inc | SNDX | Health Care | 0.80% | $1.41M |
| Corvus Pharmaceuticals Inc | CRVS | Health Care | 0.76% | $1.35M |
| Regeneron Pharmaceuticals Inc | REGN | Health Care | 0.75% | $1.31M |
| ArriVent Biopharma Inc | AVBP | Health Care | 0.73% | $1.29M |
| Chugai Pharmaceutical Co Ltd | 4519 | Health Care | 0.67% | $1.17M |
| Iovance Biotherapeutics Inc | IOVA | Health Care | 0.65% | $1.15M |
| Inhibrx Biosciences Inc | INBX | Health Care | 0.60% | $1.06M |
| Olema Pharmaceuticals Inc | OLMA | Health Care | 0.60% | $1.05M |
| Cullinan Therapeutics Inc | CGEM | Health Care | 0.59% | $1.03M |
| Natera Inc | NTRA | Health Care | 0.54% | $946.64K |
| First Tracks Biotherapeutics Inc | TRAX | Health Care | 0.53% | $932.37K |
| Immunocore Holdings PLC | IMCR | Health Care | 0.51% | $891.23K |
| BridgeBio Oncology Therapeutics Inc | BBOT | Health Care | 0.48% | $837.25K |
| CytomX Therapeutics Inc | CTMX | Health Care | 0.47% | $824.35K |
| HUTCHMED China Ltd | HCM | Health Care | 0.44% | $776.57K |
| Arvinas Inc | ARVN | Health Care | 0.43% | $755.43K |
| Janux Therapeutics Inc | JANX | Health Care | 0.43% | $751.71K |
| Adlai Nortye Ltd | ANL | Health Care | 0.30% | $529.59K |
| Tyra Biosciences Inc | TYRA | Health Care | 0.30% | $527.21K |
| ORIC Pharmaceuticals Inc | ORIC | Health Care | 0.28% | $489.91K |
| SELLAS Life Sciences Group Inc | SLS | Health Care | 0.22% | $378.94K |
CANC Sector Allocation
Tema Oncology ETF holdings grouped by sector, by share of the portfolio's market value.
| Sector | Weight | Holdings |
|---|---|---|
| Health Care | 98.9% | 56 |
| Funds & ETFs | 1.1% | 1 |
CANC Country Allocation
Where Tema Oncology ETF's holdings are domiciled, by percentage of net assets (largest 9).
| Country | % of net assets |
|---|---|
| United States | 80.9% |
| Switzerland | 8.2% |
| United Kingdom | 4.0% |
| Denmark | 2.4% |
| China | 2.0% |
| Germany | 1.1% |
| Japan | 0.7% |
| Hong Kong SAR China | 0.4% |
| Cayman Islands | 0.3% |
CANC Portfolio Allocation
Asset-class allocation of Tema Oncology ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.0% |
| Cash & Equivalents | 1.1% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.